18F-NaF PET

DIAGNOSTIC_TEST2 trials

Sponsors

University of Edinburgh, Cedars-Sinai Medical Center

Conditions

Cardiac AmyloidosisCardiovascular DiseaseHyperlipidemia

Phase 3

Effect of Evolocumab on Coronary Atherosclerosis

CompletedNCT03689946

Cedars-Sinai Medical CenterCardiovascular Disease, Hyperlipidemia

Start: 2019-03-19End: 2023-05-30Updated: 2024-07-17

Unknown Phase

PET/MR Imaging In Patients With Cardiac Amyloidosis

CompletedNCT03626584

University of EdinburghCardiac Amyloidosis

Start: 2017-08-25End: 2020-02-06Updated: 2024-05-17

Related Papers

Effects of Evolocumab on Coronary Plaque Composition and Microcalcification Activity by Coronary PET and CT Angiography.

2025-04-025 citations

Head-to-head comparison of <sup>18</sup>F-sodium fluoride coronary PET imaging between a silicon photomultiplier with digital photon counting and conventional scanners.

2024-09-272 citations